John Poyhonen, Director at HERON THERAPEUTICS, INC. /DE/ (HRTX), bought 10,000 shares at $12.20 ($122K) on 2017-01-19, disclosed to the SEC on 2017-01-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| SNMX | BUY | 2017-03-23 | $49K | — | Filing → |
| SNMX | SELL | 2014-06-06 | $301K | — | Filing → |
| RDEA | SELL | 2011-06-03 | $136K | — | Filing → |